Bioequivalence Study of Pramipexole Dihydrochloride Extended-release Tablets in Healthy Chinese Subjects

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2026
The study compared pramipexole dihydrochloride extended-release tablets (Test formulation) by Haisco Pharmaceutical Group Co., Ltd. with the reference formulation (MIRAPEX ER®,Boehringer Ingelheim GmbH of Germany) to evaluate the bioequivalence of single dose in Chinese healthy subjects under fasting and fed conditions.
Epistemonikos ID: 92869f13946ceee95c6ba37b6c904778abf9533e
First added on: Apr 10, 2026